{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:25Z","timestamp":1786116745491,"version":"build-2736575974"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:21:57Z","timestamp":1780658517000},"page":"499-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medications that Cause Fetal Anomalies and Possible Prevention Strategies"],"prefix":"10.1016","volume":"53","author":[{"given":"Rebecca","family":"Nunge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Krsti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Obi\u010dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2026.04.004_bib1","unstructured":"Hales B., Scialli A., Tassinari M., Teratology primer. Third, Available at: https:\/\/www.birthdefectsresearch.org\/primer\/ (Accessed 8 March 2026), 2018."},{"issue":"10","key":"10.1016\/j.clp.2026.04.004_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/bdr2.2015","article-title":"Comparative anatomy, pre and postnatal changes during the development and maturation of the small intestine: life-stage influences on exposure","volume":"114","author":"DeSesso","year":"2022","journal-title":"Birth Defects Res"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/bdra.23029","article-title":"The all or none phenomenon revisited","volume":"94","author":"Adam","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"7216","key":"10.1016\/j.clp.2026.04.004_bib5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(61)90927-8","article-title":"Thalidomide and congenital abnormalities","volume":"278","author":"Mcbride","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2026.04.004_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/978-1-62703-131-8_36","article-title":"The thalidomide disaster, lessons from the past","author":"Ridings","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.clp.2026.04.004_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/tera.10059","article-title":"Dose response in human teratology","volume":"65","author":"Shepard","year":"2002","journal-title":"Teratology"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/tera.1420380607","article-title":"Teratogen update: lithium","volume":"38","author":"Warkany","year":"1988","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.clp.2026.04.004_bib9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ncl.2009.06.006","article-title":"Teratogenic effects of antiepileptic medications","volume":"27","author":"Tomson","year":"2009","journal-title":"Neurol Clin"},{"issue":"15","key":"10.1016\/j.clp.2026.04.004_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/bdr2.1745","article-title":"Teratogen update: topical use and third generation retinoids","volume":"112","author":"Williams","year":"2020","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.clp.2026.04.004_bib11","doi-asserted-by":"crossref","unstructured":"Wilson J.G., Current Status of Teratology: General Principles and Mechanisms Derived from Animal Studies. 1977. Available at: https:\/\/doi.org\/10.1007\/978-1-4684-2850-6_2.","DOI":"10.1007\/978-1-4684-2850-6_2"},{"issue":"4","key":"10.1016\/j.clp.2026.04.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2025.152025","article-title":"The evolution of teratology: historical perspectives and lessons learned","volume":"49","author":"Obi\u010dan","year":"2025","journal-title":"Semin Perinatol"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajmg.c.30310","article-title":"Teratogenic exposures","volume":"157","author":"Obi\u010dan","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/ijms23031369","article-title":"Epilepsy in pregnancy\u2014management principles and focus on valproate","volume":"23","author":"B\u0142aszczyk","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clp.2026.04.004_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.12680","article-title":"Prenatal exposure to valproic acid across various indications for use","volume":"7","author":"Smolinski","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clp.2026.04.004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2023.107292","article-title":"Neurodevelopmental outcomes in children and adults with fetal valproate spectrum disorder: a contribution from the ConcePTION project","volume":"100","author":"Bluett-Duncan","year":"2023","journal-title":"Neurotoxicol Teratol"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1017\/S1092852924002311","article-title":"Anatomical, behavioral, and cognitive teratogenicity associated with valproic acid: a systematic review","volume":"29","author":"Valentino","year":"2024","journal-title":"CNS Spectr"},{"key":"10.1016\/j.clp.2026.04.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109219","article-title":"Specific fetal malformations following intrauterine exposure to antiseizure medication","volume":"142","author":"Vajda","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"11","key":"10.1016\/j.clp.2026.04.004_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1212\/WNL.0b013e3182a43e81","article-title":"Dose dependence of fetal malformations associated with valproate","volume":"81","author":"Vajda","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.clp.2026.04.004_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann Epidemiol"},{"issue":"10","key":"10.1016\/j.clp.2026.04.004_bib23","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1528-1167.2010.02668.x","article-title":"Early cognitive development in children born to women with epilepsy: a prospective report","volume":"51","author":"Bromley","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.clp.2026.04.004_bib24","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"2017","author":"Weston","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.57.2.321","article-title":"Is carbamazepine teratogenic?","volume":"57","author":"Diav-Citrin","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.clp.2026.04.004_bib27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland epilepsy and pregnancy registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib28","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.clp.2026.04.004_bib29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.clp.2026.04.004_bib31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1037\/neu0000465","article-title":"Memory dysfunction in school-aged children exposed prenatally to antiepileptic drugs","volume":"32","author":"Barton","year":"2018","journal-title":"Neuropsychology"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib33","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"2023","author":"Bromley","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(75)80604-4","article-title":"The fetal hydantoin syndrome","volume":"87","author":"Hanson","year":"1975","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2026.04.004_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jpeds.2017.05.018","article-title":"Fetal hydantoin syndrome","volume":"188","author":"Hegde","year":"2017","journal-title":"J Pediatr"},{"issue":"7645","key":"10.1016\/j.clp.2026.04.004_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(70)91597-7","article-title":"Neonatal h\u00e6morrhage following maternal anticonvulsant therapy","volume":"295","author":"Evans","year":"1970","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.clp.2026.04.004_bib37","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.22.11.1165","article-title":"Coagulation defects caused by diphenylhydantoin","volume":"22","author":"Solomon","year":"1972","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0002-9378(12)90846-7","article-title":"Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy","volume":"168","author":"Cornelissen","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib39","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0002-9378(12)90839-X","article-title":"Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency","volume":"168","author":"Cornelissen","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.clp.2026.04.004_bib40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"issue":"oct18 1","key":"10.1016\/j.clp.2026.04.004_bib41","doi-asserted-by":"crossref","first-page":"d5931","DOI":"10.1136\/bmj.d5931","article-title":"Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study","volume":"343","author":"Li","year":"2011","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.clp.2026.04.004_bib42","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.1992.03480180031008","article-title":"Warnings on use of ACE inhibitors in second and third trimester of pregnancy","volume":"267","year":"1992","journal-title":"JAMA, J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib43","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00467-008-1091-8","article-title":"Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker","volume":"24","author":"Miura","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/17512433.2015.1005074","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits","volume":"8","author":"Pucci","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.reprotox.2009.02.004","article-title":"Angiotensin II receptor blockers in pregnancy: a report of five cases","volume":"28","author":"Gersak","year":"2009","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bdra.20102","article-title":"Angiotensin II receptor antagonist treatment during pregnancy","volume":"73","author":"Alwan","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024304","article-title":"Use of angiotensin II receptor blocker during pregnancy","volume":"100","author":"Wei","year":"2021","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.clp.2026.04.004_bib48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pd.3960","article-title":"Prognosis and outcome of pregnancies exposed to renin\u2013angiotensin system blockers","volume":"32","author":"Spaggiari","year":"2012","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/AOG.0000000000001775","article-title":"Angiotensin-converting enzyme inhibitors and the risk of congenital malformations","volume":"129","author":"Bateman","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib50","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00392-018-1234-2","article-title":"Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study","volume":"107","author":"Hoeltzenbein","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3453","article-title":"Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis","volume":"37","author":"Fu","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clp.2026.04.004_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2024.08.004","article-title":"ACE inhibitor and angiotensin receptor blocker use during pregnancy: data from the ESC registry of pregnancy and cardiac disease (ROPAC)","volume":"230","author":"van der Zande","year":"2024","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/tera.1420470605","article-title":"Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy","volume":"47","author":"Feldkamp","year":"1993","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib55","first-page":"E1","article-title":"When a fetus survives methotrexate exposure","volume":"61","author":"Donoway","year":"2012","journal-title":"J Fam Pract"},{"issue":"4","key":"10.1016\/j.clp.2026.04.004_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijgo.2013.03.026","article-title":"New anomalies due to methotrexate and misoprostol exposure in early pregnancy","volume":"122","author":"MacDonald","year":"2013","journal-title":"Int J Gynecol Obstet"},{"issue":"11\u201312","key":"10.1016\/j.clp.2026.04.004_bib58","first-page":"609","article-title":"Fetal myelomeningocele after maternal methotrexate administration: a case report","volume":"61","author":"Martino","year":"2016","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clp.2026.04.004_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reprotox.2019.05.066","article-title":"Fetal methotrexate syndrome: a systematic review of case reports","volume":"87","author":"Verberne","year":"2019","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9","article-title":"Adult and two children with fetal methotrexate syndrome","volume":"57","author":"Bawle","year":"1998","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H","article-title":"Developmental delay in fetal aminopterin\/methotrexate syndrome","volume":"60","author":"Del Campo","year":"1999","journal-title":"Teratology"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib62","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0022-3476(68)80430-5","article-title":"Methotrexate-induced congenital malformations","volume":"72","author":"Milunsky","year":"1968","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.reprotox.2008.11.055","article-title":"The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy","volume":"27","author":"Svirsky","year":"2009","journal-title":"Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib64","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2008.10.027","article-title":"Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women","volume":"112","author":"Braga","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clp.2026.04.004_bib65","article-title":"Cyclophosphamide capsule: label information","year":"2024","journal-title":"DailyMed"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib66","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1191\/0961203305lu2169oa","article-title":"Cyclophosphamide for lupus during pregnancy","volume":"14","author":"Clowse","year":"2005","journal-title":"Lupus"},{"issue":"3 Pt 2","key":"10.1016\/j.clp.2026.04.004_bib67","first-page":"462","article-title":"Teratogenic effects of first-trimester cyclophosphamide therapy","volume":"72","author":"Kirshon","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.0.CO;2-V","article-title":"Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?","volume":"86","author":"Enns","year":"1999","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1471-0528.1968.tb02083.x","article-title":"Cytotoxic drugs in pregnancy","volume":"75","author":"Oliphant Nicholson","year":"1968","journal-title":"BJOG"},{"issue":"4\u20135","key":"10.1016\/j.clp.2026.04.004_bib70","first-page":"679","article-title":"Treatment of acute leukemia during pregnancy: presentation of nine cases","volume":"64","author":"Pizzuto","year":"1980","journal-title":"Cancer Treat Rep"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib71","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41416-019-0563-x","article-title":"In utero exposure to breast cancer treatment: a population-based perinatal outcome study","volume":"121","author":"Safi","year":"2019","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.reprotox.2003.10.014","article-title":"Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta)","volume":"18","author":"Matalon","year":"2004","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.clp.2026.04.004_bib73","article-title":"Coumadin-warfarin sodium tablet","year":"2012","journal-title":"DailyMed"},{"issue":"7991","key":"10.1016\/j.clp.2026.04.004_bib74","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(76)90587-0","article-title":"WARFARIN-INDUCED fetal abnormalities","volume":"308","author":"Holzgreve","year":"1976","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib75","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves","volume":"160","author":"Chan","year":"2000","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/tera.10054","article-title":"Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis","volume":"66","author":"Van Driel","year":"2002","journal-title":"Teratology"},{"issue":"9","key":"10.1016\/j.clp.2026.04.004_bib77","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.CIR.0000060806.86686.EC","article-title":"Prosthetic heart valves and pregnancy","volume":"107","author":"Hung","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/tera.1420320302","article-title":"Congenital dandy walker malformation associated with first trimester warfarin: a case report and literature review","volume":"32","author":"Kaplan","year":"1985","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jocn.2006.03.031","article-title":"Neurological sequelae of intrauterine warfarin exposure","volume":"14","author":"Raghav","year":"2007","journal-title":"J Clin Neurosci"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib80","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00431-005-0064-1","article-title":"Coumarin embryopathy in an extremely low birth weight infant associated with neonatal hepatitis and ocular malformations","volume":"165","author":"Hetzel","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clp.2026.04.004_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/987940","article-title":"Warfarin-associated diaphragmatic hernia: an unusual diagnosis","volume":"2015","author":"Vilhena","year":"2015","journal-title":"Case Rep Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib82","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"Am J Med"},{"issue":"3 Pt 2","key":"10.1016\/j.clp.2026.04.004_bib83","first-page":"I169","article-title":"The problem of cardiac valve prostheses, anticoagulants, and pregnancy","volume":"70","author":"Salazar","year":"1984","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib84","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/icvts\/ivs178","article-title":"Is there a suitable method of anticoagulation in pregnant patients with mechanical prosthetic heart valves?","volume":"15","author":"Malik","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib85","first-page":"35","article-title":"Risk of warfarin during pregnancy with mechanical valve prostheses","volume":"99","author":"Cotrufo","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2000.tb11696.x","article-title":"Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves","volume":"107","author":"Sadler","year":"2000","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0020-7292(02)00186-8","article-title":"The risk of fetal loss associated with Warfarin anticoagulation","volume":"78","author":"Blickstein","year":"2002","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib88","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2165\/00003495-199651020-00007","article-title":"Mycophenolate mofetil","volume":"51","author":"Fulton","year":"1996","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.reprotox.2009.02.007","article-title":"Tetrada of the possible mycophenolate mofetil embryopathy: a review","volume":"28","author":"Merlob","year":"2009","journal-title":"Reprod Toxicol"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmg.2016.09.014","article-title":"Mycophenolate mofetil embryopathy: a newly recognized teratogenic syndrome","volume":"60","author":"Perez-Aytes","year":"2017","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib92","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ajt.13928","article-title":"Pregnancy outcomes related to mycophenolate exposure in female kidney transplant recipients","volume":"17","author":"King","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM200101043440107","article-title":"Misoprostol and pregnancy","volume":"344","author":"Goldberg","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.004_bib94","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2016.11.007","article-title":"Misoprostol exposure during the first trimester of pregnancy: is the malformation risk varying depending on the indication?","volume":"207","author":"Auffret","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clp.2026.04.004_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108488","article-title":"Teratogenicity and reactive oxygen species after transient embryonic hypoxia: experimental and clinical evidence with focus on drugs causing failed abortion in humans","volume":"122","author":"Danielsson","year":"2023","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.clp.2026.04.004_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110132","article-title":"Effectiveness and safety of misoprostol-only for first-trimester medication abortion: an updated systematic review and meta-analysis","volume":"127","author":"Raymond","year":"2023","journal-title":"Contraception"},{"issue":"9116","key":"10.1016\/j.clp.2026.04.004_bib97","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(97)12363-7","article-title":"Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy","volume":"351","author":"Gonzalez","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib99","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.1542\/peds.2010-0945","article-title":"Choanal atresia associated with tracheoesophageal fistula: the spectrum of carbimazole embryopathy","volume":"128","author":"Douchement","year":"2011","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ajmg.a.33705","article-title":"Grade 1 microtia, wide anterior fontanel and novel type tracheo-esophageal fistula in methimazole embryopathy","volume":"155","author":"Gripp","year":"2011","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib101","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1470.2011.01572.x","article-title":"Aplasia Cutis Congenita and other anomalies associated with methimazole exposure during pregnancy","volume":"28","author":"RODR\u00cdGUEZ-GARC\u00cdA","year":"2011","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/qjmed\/hcq248","article-title":"Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy","volume":"105","author":"Bowman","year":"2012","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9378(13)70286-2","article-title":"A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy","volume":"170","author":"Wing","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib104","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-45-6-1187","article-title":"The placental transfer of propylthiouracil, methimazole and carbimazole","volume":"45","author":"Marchant","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/bdra.23012","article-title":"Pharmacologic treatment of hyperthyroidism during pregnancy","volume":"94","author":"Cassina","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.clp.2026.04.004_bib106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.earlhumdev.2016.06.006","article-title":"Pregnancy outcomes after fetal exposure to antithyroid medications or levothyroxine","volume":"101","author":"Schurmann","year":"2016","journal-title":"Early Hum Dev"},{"issue":"23","key":"10.1016\/j.clp.2026.04.004_bib108","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","article-title":"Lithium use in pregnancy and the risk of cardiac malformations","volume":"376","author":"Patorno","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib109","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am J Psychiatr"},{"issue":"4","key":"10.1016\/j.clp.2026.04.004_bib110","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1017\/S1047951116001025","article-title":"The changing epidemiology of Ebstein\u2019s anomaly and its relationship with maternal mental health conditions: a European registry-based study","volume":"27","author":"Boyle","year":"2017","journal-title":"Cardiol Young"},{"issue":"8","key":"10.1016\/j.clp.2026.04.004_bib111","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S2215-0366(18)30180-9","article-title":"Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies","volume":"5","author":"Munk-Olsen","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.clp.2026.04.004_bib112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11920-015-0658-x","article-title":"Bipolar disorder in pregnancy and postpartum: principles of management","volume":"18","author":"Khan","year":"2016","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib113","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/AOG.0000000000003013","article-title":"ACOG Committee Opinion No. 762: prepregnancy counseling","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"0910","key":"10.1016\/j.clp.2026.04.004_bib115","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2014.13936","article-title":"Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey","volume":"144","author":"Csajka","year":"2014","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib116","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/j.1552-4604.2000.tb05982.x","article-title":"Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals","volume":"40","author":"Pole","year":"2000","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib117","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2014.07.034","article-title":"Discontinuation of antipsychotic medication in pregnancy: a cohort study","volume":"159","author":"Petersen","year":"2014","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib118","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajmg.c.30308","article-title":"The art and science of teratogen risk communication","volume":"157","author":"Conover","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"10.1016\/j.clp.2026.04.004_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.2325","article-title":"Impact of perinatal exposure counseling on patient reported emotional outcomes and decisional empowerment","volume":"116","author":"M\u00fcller","year":"2024","journal-title":"Birth Defects Res"},{"issue":"Supplement_3","key":"10.1016\/j.clp.2026.04.004_bib120","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1542\/peds.113.S3.984","article-title":"Utilization of animal studies to determine the effects and human risks of environmental toxicants (Drugs, chemicals, and physical agents)","volume":"113","author":"Brent","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib121","first-page":"44","article-title":"Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling","volume":"26","author":"Einarson","year":"2001","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.clp.2026.04.004_bib122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jwh.2022.0205","article-title":"Behaviors related to medication safety and use during pregnancy","volume":"32","author":"Head","year":"2023","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"10.1016\/j.clp.2026.04.004_bib123","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/tera.1420410602","article-title":"Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester","volume":"41","author":"Koren","year":"1990","journal-title":"Teratology"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:13:39Z","timestamp":1786018419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000333"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.004","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications that Cause Fetal Anomalies and Possible Prevention Strategies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}